Article
Inhibition of PP2A activity confers a TRAIL-sensitive phenotype during malignant transformation.
Molecular cancer research : MCR - 1 Feb 2014
Yang Hongmei, Chen Xuanyu, Wang Xuegang, Li Yansheng, Chen Shaoyong, Qian Xiaohui, Wang Rong, Chen Li, Han Weiwei, Ruan Anming, Du Quansheng, Olumi Aria F, Zhang Xiaoping
Abstract excerpt
UNLABELLED: TRAIL is a promising anticancer agent because it induces apoptosis in the majority of human cancer cells but spares the normal cells. To determine the mechanistic nature of how normal cells acquire a TRAIL-sensitive phenotype during the process of malignant transformation, an experime...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
